JBM (Healthcare) Limited

SEHK:2161 Stock Report

Market Cap: HK$839.2m

JBM (Healthcare) Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for JBM (Healthcare).

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth10.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

Nov 01
Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Jul 29
JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Aug 03
Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Jul 28
Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as JBM (Healthcare) has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:2161 - Analysts future estimates and past financials data (HKD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2024648130181191N/A
12/31/2023629114156168N/A
9/30/202361098130144N/A
6/30/202356578134145N/A
3/31/202352057137146N/A
12/31/202248747122129N/A
9/30/202245436106113N/A
6/30/2022430307987N/A
3/31/2022406255360N/A
12/31/2021398183038N/A
9/30/202139011816N/A
6/30/2021394172237N/A
3/31/2021397233659N/A
3/31/2020382413438N/A
3/31/2019308524857N/A
3/31/2018264427282N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 2161's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if 2161's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 2161's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 2161's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 2161's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 2161's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.